ACP3 and prostate cancer: Because we found a higher PAP abundance in recurrent prostate cancer compared to nonrecurrent prostate cancer in our initial 2D-DIGE study of prostate cancer tissue, we used MRM-MS to determine the PAP concentrations in the urine of prostate cancer patients with and without relapse.